Integra Lifesciences Holdings Stock In The News

IART Stock  USD 31.63  0.31  0.97%   
The overall news coverage of Integra LifeSciences Holdings from major news outlets shows bullish sentiment on 8 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of Integra LifeSciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Integra LifeSciences Holdings. The specific impact of Integra LifeSciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Integra LifeSciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Integra LifeSciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Integra LifeSciences Backtesting and Integra LifeSciences Hype Analysis.

Integra LifeSciences Today Top News and Investor Outlook

Yahoo News
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024
https://finance.yahoo.com/news/integra-lifesciences-reschedule-first-quarter-212400610.html
 Bullish
Yahoo News
Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
https://finance.yahoo.com/news/edwards-lifesciences-ew-earnings-expected-140151266.html
 Bullish
Yahoo News
Earnings Preview: Integra LifeSciences (IART) Q1 Earnings Expected to Decline
https://finance.yahoo.com/news/earnings-preview-integra-lifesciences-iart-140118723.html
 Bullish
Yahoo News
Integra LifeSciences Completes the Acquisition of Acclarent, Inc.
https://finance.yahoo.com/news/integra-lifesciences-completes-acquisition-acclarent-201500346.html
 Neutral
Yahoo News
11 Oversold Healthcare Stocks To Buy Right Now
https://finance.yahoo.com/news/11-oversold-healthcare-stocks-buy-121714179.html
 Bullish
Yahoo News
Q4 2023 Integra Lifesciences Holdings Corp Earnings Call
https://finance.yahoo.com/news/q4-2023-integra-lifesciences-holdings-034618032.html
 Bullish
Yahoo News
Integra Lifesciences Reports Subdued Earnings Amidst Market Stability and Product Resilience
https://finance.yahoo.com/news/integra-lifesciences-reports-subdued-earnings-113218839.html
 Bullish
Yahoo News
Integra LifeSciences Announces Leadership Transition Plan
https://finance.yahoo.com/news/integra-lifesciences-announces-leadership-transition-110000513.html
 Bullish
Yahoo News
Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
https://finance.yahoo.com/news/integra-lifesciences-reports-fourth-quarter-110000317.html
 Bullish
Yahoo News
Integra (IART) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
https://finance.yahoo.com/news/integra-iart-q4-earnings-preview-141558017.html
 Bullish

Integra LifeSciences Holdings Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Integra and other traded companies coverage. We help investors stay connected with Integra headlines for the 19th of April to make an informed investment decision based on correlating the impacts of news items on Integra Stock performance. Please note that trading solely based on the Integra LifeSciences Holdings hype is not for everyone as timely availability and quick action are needed to avoid losses.
Integra LifeSciences' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Integra LifeSciences Holdings investors visualize upcoming and past events in order to time the market based on Integra LifeSciences Holdings noise-free hype analysis.
Integra LifeSciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Integra earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Integra LifeSciences that are available to investors today. That information is available publicly through Integra media outlets and privately through word of mouth or via Integra internal channels. However, regardless of the origin, that massive amount of Integra data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Integra LifeSciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Integra LifeSciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Integra LifeSciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Integra LifeSciences alpha.

Integra Largest EPS Surprises

Earnings surprises can significantly impact Integra LifeSciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2003-04-25
2003-03-310.080.090.0112 
2002-08-01
2002-06-300.060.070.0116 
2002-05-08
2002-03-310.060.070.0116 
2002-02-27
2001-12-310.050.060.0120 
2001-08-02
2001-06-300.030.040.0133 
2001-05-09
2001-03-310.030.040.0133 
View All Earnings Estimates

Integra LifeSciences Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Integra LifeSciences Stock. The global stock market is bearish. About 66% of major world exchanges and indexes are down. See today's market update for more information.
Macroaxis News: globenewswire.com
18th of April 2024
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Cal...
at globenewswire.com 
Yahoo News
16th of April 2024
Qlik Sets the Pace for Real-World AI Business Transformations Across Industries
at finance.yahoo.com 
news
9th of April 2024
2025 Acura MDX ditches touchpad, embraces touchscreens, Google, Bang Olufsen
at autoblog.com 
Investing News at Macroaxis
3rd of April 2024
Citi upgrades Integra LifeSciences stock, sees challenges as priced in
at investing.com 
news
2nd of April 2024
Integra LifeSciences completes acquisition of JJs Acclarent
at massdevice.com 
benzinga news
1st of April 2024
Integra LifeSciences Completes the Acquisition of Acclarent, Inc.
at benzinga.com 
Yahoo News
25th of March 2024
Turkish Broker Integra Licenses CyberCube Software to Bolster Cyber Growth
at finance.yahoo.com 
Yahoo News
20th of March 2024
INTEGRA ANNOUNCES LISTING OF WARRANTS
at finance.yahoo.com 
news
8th of March 2024
Surgical Retractors Market to Hit USD 3.17 Billion by 2030 - Exclusive Report by SNS Insid...
at kalkinemedia.com 
Gurufocus Stories at Macroaxis
5th of March 2024
Integra Lifesciences Holdings Corp Investor Day Transcript
at gurufocus.com 

Integra LifeSciences Investors Sentiment

The influence of Integra LifeSciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Integra. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Integra LifeSciences' public news can be used to forecast risks associated with an investment in Integra. The trend in average sentiment can be used to explain how an investor holding Integra can time the market purely based on public headlines and social activities around Integra LifeSciences Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Integra LifeSciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Integra LifeSciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Integra LifeSciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Integra LifeSciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Integra LifeSciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Integra LifeSciences' short interest history, or implied volatility extrapolated from Integra LifeSciences options trading.
When determining whether Integra LifeSciences is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Integra Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Integra Lifesciences Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Integra Lifesciences Holdings Stock:

Complementary Tools for Integra Stock analysis

When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Is Integra LifeSciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Integra LifeSciences. If investors know Integra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Integra LifeSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.60)
Earnings Share
0.84
Revenue Per Share
19.248
Quarterly Revenue Growth
(0)
Return On Assets
0.0424
The market value of Integra LifeSciences is measured differently than its book value, which is the value of Integra that is recorded on the company's balance sheet. Investors also form their own opinion of Integra LifeSciences' value that differs from its market value or its book value, called intrinsic value, which is Integra LifeSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Integra LifeSciences' market value can be influenced by many factors that don't directly affect Integra LifeSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Integra LifeSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Integra LifeSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Integra LifeSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.